{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:44:45Z","timestamp":1785739485481,"version":"3.56.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019573","name":"Amsterdam UMC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019573","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Endocrinology and Metabolism"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What are the psychological and physical effects of short-term discontinuation and subsequent reinitiation of feminizing gender-affirming hormone therapy (fGAHT) in older transgender women receiving long-term therapy?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Short-term fGAHT discontinuation increased estradiol deprivation-related symptoms while reinitiation showed opposite effects, and psychological well-being was not affected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>With growing numbers of older transgender individuals, questions arise regarding the necessity of long-term continuation of fGAHT, particularly since cisgender women have low estradiol concentrations after menopause. However, data on the effects of fGAHT discontinuation in older transgender women are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>This within-subject clinical trial included 19 participants and was conducted in 2024 and 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Transgender women aged \u226555\u2009years (median age 66\u2009years), on fGAHT for \u22655\u2009years (median 23\u2009years), were recruited from the Center of Expertise on Gender Dysphoria, Amsterdam, the Netherlands. Estradiol deprivation-related symptoms, sleep quality, quality of life, mental health, and body image were assessed via questionnaires at baseline, 12\u2009weeks after fGAHT discontinuation, and 12\u2009weeks after reinitiation. Outcomes were analyzed using multilevel models. Differences were considered substantial based on 95% CIs and \u226510% change between measurements. Perceived psychological and physical changes and willingness to permanently discontinue fGAHT were also assessed via open-ended questions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>Experiences varied, but after discontinuation, unfavorable mean changes were found for somato-vegetative symptoms (\u03b2 0.4, 95% CI \u22120.7 to 1.5, %\u0394 11.5), sleep disturbance (OR 1.6, 95% CI 0.2 to 10.3, %\u0394 10.7), and happiness to a lesser extent (\u03b2 \u22120.5, 95% CI \u22120.9 to \u22120.1, %\u0394 \u22126.4). Reinitiation showed favorable changes for somato-vegetative and total estradiol deprivation-related symptoms (\u03b2 \u22120.8, 95% CI \u22121.9 to 0.3, %\u0394 \u221222.1; \u03b2 \u22123.0, 95% CI \u22124.8 to \u22121.2, %\u0394 \u221236.3), total sleep quality (\u03b2 \u22120.7, 95% CI \u22121.5 to 0.2, %\u0394 \u221210.3), sleep onset latency (\u03b2 \u22122.8, 95% CI \u22128.1 to 2.5, %\u0394 \u221214.9), and sleep disturbance (OR 0.1, 95% CI 0.0 to 1.0, %\u0394 \u221246.6). No mean differences were found for depressive symptoms, anxiety, quality of life, or body satisfaction. Perceived psychological and physical changes were diverse and generally aligned with known menopause-related changes. One participant wished to permanently stop fGAHT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The study was not blinded or placebo-controlled, which may have introduced expectancy bias. The small clinical sample may limit generalizability to the broader population of transgender women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Transgender women, like cisgender women, experience symptoms in response to estradiol deprivation, which may support the continuation of fGAHT in older age. This study did not identify psychological or body image barriers to discontinuation for those who wish to stop.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>Funded by an Amsterdam UMC PhD scholarship to J.O.v.H. and by departmental funds from the Department of Endocrinology and Metabolism, Amsterdam UMC, location VUmc. K.M.A.D. declares receipt of consulting fees from Recordati, paid to their institution. The other authors declare no competing interests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>This study was registered in the EU Clinical Trials Register (EUCTR2023-505143-39-00).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deag087","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:19:05Z","timestamp":1778498345000},"page":"1387-1396","source":"Crossref","is-referenced-by-count":0,"title":["Psychological and physical effects of short-term discontinuation of feminizing gender-affirming hormone therapy among older transgender women: a within-subject clinical trial"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6941-1815","authenticated-orcid":false,"given":"J O","family":"van Heesewijk","sequence":"first","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Department of Endocrinology and Metabolism, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Amsterdam Public Health (APH) Research Institute, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Department of Medical Psychology, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E S","family":"Geels","sequence":"additional","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Department of Endocrinology and Metabolism, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"den Heijer","sequence":"additional","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Department of Endocrinology and Metabolism, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-3502","authenticated-orcid":false,"given":"K M A","family":"Dreijerink","sequence":"additional","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Department of Endocrinology and Metabolism, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B P C","family":"Kreukels","sequence":"additional","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Amsterdam Public Health (APH) Research Institute, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]},{"name":"Department of Medical Psychology, Amsterdam UMC, Location VUmc , Amsterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"2026080301512789800_deag087-B1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR","author":"American Psychiatric Association","year":"2022","edition":", 5th edn"},{"key":"2026080301512789800_deag087-B2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS Recommendations on women\u2019s midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"2026080301512789800_deag087-B3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"2026080301512789800_deag087-B4","volume-title":"The Pattern of Human Concerns","author":"Cantril","year":"1965"},{"key":"2026080301512789800_deag087-B5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2026080301512789800_deag087-B6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"key":"2026080301512789800_deag087-B7","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2147\/NDT.S95310","article-title":"The effect of cross-sex hormonal treatment on gender dysphoria individuals\u2019 mental health: a systematic review","volume":"12","author":"Costa","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2026080301512789800_deag087-B8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41574-022-00685-4","article-title":"Treating menopause\u2014MHT and beyond","volume":"18","author":"Davis","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2026080301512789800_deag087-B9","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/nrdp.2015.4","article-title":"Menopause","volume":"1","author":"Davis","year":"2015","journal-title":"Nat Rev Dis Primers."},{"key":"2026080301512789800_deag087-B10","first-page":"1","article-title":"Long term hormonal treatment for transgender people","volume":"359","author":"den Heijer","year":"2017","journal-title":"Br Med J"},{"key":"2026080301512789800_deag087-B11","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41562-023-01605-w","article-title":"A systematic review of psychosocial functioning changes after gender-affirming hormone therapy among transgender people","volume":"7","author":"Doyle","year":"2023","journal-title":"Nat Hum Behav."},{"key":"2026080301512789800_deag087-B12","first-page":"47","volume-title":"Intersections of Ageing, Gender and Sexualities: Multidisciplinary International Perspectives","author":"Fabbre","year":"2019"},{"key":"2026080301512789800_deag087-B13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/00989134-20220304-03","article-title":"Advancing gerontological health research with sexual and gender minorities across the globe","volume":"48","author":"Flatt","year":"2022","journal-title":"J Gerontol Nurs"},{"key":"2026080301512789800_deag087-B14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0956797612458805","article-title":"Feeling worse to feel better: pain-offset relief simultaneously stimulates positive affect and reduces negative affect","volume":"24","author":"Franklin","year":"2013","journal-title":"Psychol Sci"},{"key":"2026080301512789800_deag087-B15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/geront\/gnt021","article-title":"Physical and mental health of transgender older adults: an at-risk and underserved population","volume":"54","author":"Fredriksen-Goldsen","year":"2014","journal-title":"Gerontologist"},{"key":"2026080301512789800_deag087-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/26895269.2025.2522244","article-title":"A call to action: advancing research, practice, and policy for Middle aged and older transgender and nonbinary communities","volume":"27","author":"Green","year":"2025","journal-title":"Int J Transgend Health"},{"key":"2026080301512789800_deag087-B17","first-page":"16","article-title":"[Evaluation of climacteric symptoms (Menopause Rating Scale)]","volume":"116","author":"Hauser","year":"1994","journal-title":"Zentralbl Gynakol"},{"key":"2026080301512789800_deag087-B18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1477-7525-2-45","article-title":"The Menopause Rating Scale (MRS) scale: a methodological review","volume":"2","author":"Heinemann","year":"2004","journal-title":"Health Qual Life Outcomes."},{"key":"2026080301512789800_deag087-B19","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080301512789800_deag087-B20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bpobgyn.2021.10.009","article-title":"Cognition and mental health in menopause: a review","volume":"81","author":"Hogervorst","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2026080301512789800_deag087-B21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-95031-0_2","volume-title":"Transgender and Gender Nonconforming Health and Aging","author":"Houlberg","year":"2019"},{"key":"2026080301512789800_deag087-B22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1377\/hlthaff.2012.1078","article-title":"Shared decision making: examining key elements and barriers to adoption into routine clinical practice","volume":"32","author":"Legare","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"2026080301512789800_deag087-B23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF01544272","article-title":"A body image scale for evaluating transsexuals","volume":"4","author":"Lindgren","year":"1975","journal-title":"Arch Sex Behav."},{"key":"2026080301512789800_deag087-B24","first-page":"112","volume-title":"Ital J Psychiatry","author":"Meneguzzo","year":"2024"},{"key":"2026080301512789800_deag087-B25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15532739.2018.1493626","article-title":"Transgender women\u2019s experiences and beliefs about hormone therapy through and beyond mid-age: an exploratory UK study","volume":"20","author":"Mohamed","year":"2019","journal-title":"Int J Transgend"},{"key":"2026080301512789800_deag087-B26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.sleep.2023.04.028","article-title":"Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons","volume":"107","author":"Morssinkhof","year":"2023","journal-title":"Sleep Medicine."},{"key":"2026080301512789800_deag087-B27","volume-title":"Menopause: identification and Management NICE Clinical Guidelines","author":"NICE","year":"2024"},{"key":"2026080301512789800_deag087-B28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual Life Res."},{"key":"2026080301512789800_deag087-B29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpsychores.2013.12.002","article-title":"Sleep disturbance and correlates in menopausal women in Shanghai","volume":"76","author":"Sun","year":"2014","journal-title":"J Psychosom Res."},{"key":"2026080301512789800_deag087-B30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","author":"The Whoqol G","year":"1998","journal-title":"Psychol Med"},{"key":"2026080301512789800_deag087-B31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4161\/derm.23872","article-title":"Estrogens and aging skin","volume":"5","author":"Thornton","year":"2013","journal-title":"Dermato-Endocrinology."},{"key":"2026080301512789800_deag087-B32","article-title":"Assessing of subjective well-being: a review of common measures","volume-title":"Handbook of Positive Psychology Assessment","author":"Tov"},{"key":"2026080301512789800_deag087-B33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/26895269.2024.2389924","article-title":"Experiences of menopause among non-binary and trans people","volume":"26","author":"Toze","year":"2025","journal-title":"Int J Transgend Health"},{"key":"2026080301512789800_deag087-B34","volume-title":"Trans and Gender Diverse Ageing in Care Contexts: Research into Practice","author":"Toze","year":"2024"},{"key":"2026080301512789800_deag087-B35","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jclinepi.2013.03.017","article-title":"Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis","volume":"66","author":"Twisk","year":"2013","journal-title":"J Clin Epidemiol."},{"key":"2026080301512789800_deag087-B36","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.inpsyc.2025.100049","article-title":"Mental health outcomes and loneliness in older transgender individuals receiving long-term gender-affirming hormone therapy compared with older cisgender individuals","volume":"37","author":"van Heesewijk","year":"2025","journal-title":"Int Psychogeriatr."},{"key":"2026080301512789800_deag087-B37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/26895269.2023.2289069","article-title":"Cognitive functioning in older transgender individuals receiving long-term gender-affirming hormone therapy","volume":"26","author":"van Heesewijk","year":"2023","journal-title":"Int J Transgend Heal"},{"key":"2026080301512789800_deag087-B38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/jwh.2012.3719","article-title":"The impact of menopausal symptoms on quality of life, productivity, and economic outcomes","volume":"22","author":"Whiteley","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"2026080301512789800_deag087-B39","doi-asserted-by":"crossref","first-page":"1460613","DOI":"10.3389\/fneur.2025.1460613","article-title":"Factors influencing sleep disorders in perimenopausal women: a systematic review and meta-analysis","volume":"16","author":"Zeng","year":"2025","journal-title":"Front Neurol"},{"key":"2026080301512789800_deag087-B40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/gme.0b013e318196063e","article-title":"Additive effect of depressed mood and vasomotor symptoms on postmenopausal insomnia","volume":"16","author":"Zervas","year":"2009","journal-title":"Menopause"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/8\/1387\/68437608\/deag087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/8\/1387\/68437608\/deag087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:51:42Z","timestamp":1785736302000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/41\/8\/1387\/8698728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,5,30]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deag087","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,5,30]]}}}